英国授权辉瑞/ BioNTech研发的新冠疫苗全面使用

2020-12-02 JACKZHAO MedSci原创

英国周三批准了辉瑞-BioNTech联合研发的新冠疫苗用于紧急用途,并将在下周在英国推出,老年人与医务人员将排在优先接种。

据CNBC报道,英国周三批准了辉瑞-BioNTech联合研发的新冠疫苗用于紧急用途,并将在下周在英国推出,老年人与医务人员将排在优先接种。

英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。

英国政府在周三说:“政府今天已经接受了独立的药品和医疗产品监管机构(MHRA)的建议,批准使用辉瑞BioNTech的新冠疫苗。” “该疫苗将从下周开始在英国范围内销售。”

辉瑞董事长兼首席执行官阿尔伯特·布尔拉(Albert Bourla)表示,该授权是“历史性时刻”。他还表示,自从我们首次宣布科学将获胜以来,这项授权是我们一直在努力的目标。我们赞扬MHRA能够进行认真评估并及时采取行动,以保护英国人民。随着成千上万的人被感染,在结束这场毁灭性大流行的集体竞赛中,每天都很重要。

辉瑞公司和BioNTech公司在7月宣布与英国达成一项协议,将提供3000万剂其基于mRNA的疫苗(正式称为“ BNT162b2”),该疫苗一经授权可紧急使用。该协议在十月初增加到4000万剂。作为两剂疫苗,英国将有足够的疫苗剂量可接种约6600万人口的三分之一。

BioNTech周三表示,4000万剂的交付将在2020年和2021年进行,预计明年将完全交付。

周一,辉瑞和BioNTech表示,他们已向欧洲药品管理局申请了该疫苗的有条件销售许可。 BioNTech表示,如果获得授权,它可以在本月在欧洲使用该疫苗,尽管EMA随后在周二表示,它将在12月29日之前完成对该疫苗的审查。

此前有报道称,FDA已要求顾问专家团在12月初预留三天(定于12月8日至10日左右)举行可能的会议,讨论新冠疫苗的潜在授权,因此可以在不久后做出决定。

英国在此时进行疫苗接种,时间至关重要。在欧洲,其已确诊病例的数量仅次于法国和西班牙,是法国的第三高,感染病例超过160万。在欧洲,由于冠状病毒造成的死亡人数最高,但有近6万人死亡。

由于采取第二次封禁措施,每日感染的数量一直在稳步下降,该封禁在星期三取消,取而代之的是分层的限制策略,分层由该区域感染率决定。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2021-01-03 shock_melon
  2. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2021-08-11 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-04 lqvr
  4. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-03 Jessica

    英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-03 BJying

    #新冠肺炎疫苗# #辉瑞# 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-03 1211c54em14(暂无昵称)

    检验政府决策的时刻

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-02 张怀若

    不是不用吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-02 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1652452, encodeId=4fab165245249, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Sun Jan 03 08:25:28 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919179, encodeId=119119191e974, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Wed Aug 11 13:25:28 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300439, encodeId=ea411300439d9, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1391173, encodeId=2da313911e3c3, content=<a href='/topic/show?id=9c5e34585a' target=_blank style='color:#2F92EE;'>#BioNTech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3458, encryptionId=9c5e34585a, topicName=BioNTech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e3fb2500073, createdName=124987cdm26暂无昵称, createdTime=Fri Dec 04 09:25:28 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904600, encodeId=0767904600f8, content=英国政府将是全球首个正式批准将辉瑞-BioNTech注射剂广泛使用的政府,这意味着这让英国成为最早为全民接种疫苗的国家之一。英国很棒!, beContent=null, objectType=article, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211019/df01a4bfb64246379ddfef3370d04115/e1274c8eb5e440918f56f83bcfea9031.jpg, createdBy=3a345397082, createdName=Jessica, createdTime=Thu Dec 03 14:40:18 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904523, encodeId=49e3904523ae, content=<a href='/topic/show?id=babe580851a' target=_blank style='color:#2F92EE;'>#新冠肺炎疫苗#</a> <a href='/topic/show?id=952e93e2512' target=_blank style='color:#2F92EE;'>#辉瑞#</a> 在欧洲,英国已确诊病例的数量仅次于法国和西班牙,英国在此时进行疫苗接种,时间至关重要。, beContent=null, objectType=article, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58085, encryptionId=babe580851a, topicName=新冠肺炎疫苗), TopicDto(id=93725, encryptionId=952e93e2512, topicName=辉瑞)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/a16c22989a2247c0a54b44d3e3acdaaa/44abb281938b4e04bc086f8345254626.jpg, createdBy=fb825296401, createdName=BJying, createdTime=Thu Dec 03 10:38:02 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904504, encodeId=d98c904504b5, content=检验政府决策的时刻, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60182229007, createdName=1211c54em14(暂无昵称), createdTime=Thu Dec 03 09:05:56 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904436, encodeId=046690443689, content=不是不用吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/406f8efd94384014845836dbc1145ef8/2cd70ff60841419085fa1683b4048814.jpg, createdBy=465e2379549, createdName=张怀若, createdTime=Wed Dec 02 23:27:31 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028837, encodeId=8a2b102883edf, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Dec 02 21:25:28 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904396, encodeId=9962904396de, content=希望看到更多安全数据, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210315/480e12f811f44bc39b347d2521d56e86/67d0e6d503124ea685205b567af3dffd.jpg, createdBy=f9435296193, createdName=Baodongxu, createdTime=Wed Dec 02 21:20:49 CST 2020, time=2020-12-02, status=1, ipAttribution=)]
    2020-12-02 Baodongxu

    希望看到更多安全数据

    0

相关资讯

钟南山对话“00后”援鄂护士:疫苗应用至少得明年初

出生于2000年的刘家怡曾是广东援助湖北医疗队中年龄最小的一员,11月28日,年逾八旬而自我调侃“80后”的钟南山院士在广州医科大学会见了“00后”刘家

Nat Commun :艾滋病疫苗新理念,回输编程B细胞产生广谱中和抗体

艾滋病是一种危害性极大的传染病,它由感染了艾滋病病毒(HIV病毒)引起的。HIV专门攻击人体免疫系统的病毒,它结合于T淋巴细胞的CD4受体以及CCR5辅助受体,大量破坏该细胞,使人体丧失免疫功能。

辉瑞疫苗安全且95%有效,科兴触发快速免疫反应但低于康复者水平

为申请美国首次获得新冠病毒疫苗法规授权审批铺平了道路

Moderna宣布其新冠疫苗mRNA-1273有效率达94.5%

Moderna指出,在第一次中期分析中发现了11例严重COVID-19病例,而这些病例均发生在安慰剂组。

NEJM:mRNA疫苗mRNA-1273用于新冠肺炎的预防研究

mRNA-1273疫苗可诱导了抗SARS-CoV-2免疫应答,疫苗的安全性和耐受性良好,有进一步开发的潜力

阿斯利康的COVID-19候选疫苗:有效率达70%

该结果意味着黑猩猩腺病毒改良版的新冠疫苗达到了试验的主要终点。

拓展阅读

Hip Pelvis:新冠肺炎疫情对髋部骨折患者康复的影响

大流行疫情对住院护理医院的老年髋部骨折患者术后活动的恢复有不利影响,在完全限制家属进入以防止感染的情况下。

Critical Care Medicine:巴瑞替尼与c治疗重症新冠肺炎的疗效与不良反应

我们对重症新冠肺炎住院患者进行的倾向性得分匹配的回顾性观察研究显示,与托珠单抗相比,巴瑞替尼的病死率没有差异,但不良反应显著减少。

Critical Care Medicine:肾素-血管紧张素系统途径疗法与改善新冠肺炎男性住院患者预后相关

男性使用ARB与较低的机械通气和血管活性药物的使用率有关,而在女性中没有观察到该现象。RAS系统失调的性别差异可能导致COVID-19患者预后和对ARB药物反应性的性别差异。

2023年度巨献:中国中药领域十大医学研究出炉

2023年梅斯年终巨献:中国重磅级医学研究成果解读!

重磅!钟南山团队最新发表,连花清瘟的双盲、随机对照临床试验的结果出炉!

《病毒学》:与对照组相比,连花清瘟能够加速缓解多种临床症状,包括鼻塞、喉咙痛、咳嗽、发烧等等,从而促进轻至中度新冠肺炎患者的恢复。且两组安全性相当。

Lancet Respir Med:英国新冠肺炎住院后的多器官MRI发现

因新冠肺炎住院后,人们中期面临多器官异常的风险,本文发现强调了积极主动的多学科护理途径的必要性,并有可能进行成像来指导监测频率和治疗分层。